|
⚲
|
| KBI Biopharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001314013 |
| Sale | 2009-08-14 ($10.0 M Offered, $9.6 M Sold) |
| Fund | |
| Phone | 9194799898 |
| Address | 1101 Hamlin Rd Durham, 27704 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Nicholas Leb | |
| Richard Brandewie | |
| Harrington Bischof | |
| Joseph McMahon | |
| Howard Auman Jr | |
| James Hoover |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
F.N.B. Capital Partners, L.P.
✚
|
0.0 | |
|
FNB United Corp.
✚
|
0.0 | |
|
Fobes Malcolm Randall III
✚
|
0.0 | |
|
Focused Alpha Cayman Fund, Ltd.
✚
|
0.0 | |
|
Focused Alpha, LP
✚
|
0.0 | |
|
FOMO Media LLC
✚
|
0.0 | |
|
Fonemine Inc
✚
|
0.0 | |
|
Fonstein Michael
✚
|
0.0 | |
|
Force Energy Corp
✚
|
0.0 | |
|
Delic Corp
✚
|
0.0 |